Men's Hormone Care

Testosterone replacement therapy is prescription treatment that supplies testosterone from outside the body to men diagnosed with testosterone deficiency.

At Laramie Physicians Women & Wellness Clinic it is offered as injections you administer yourself, injections administered by our clinical staff at the clinic, or pellet therapy.

It treats a diagnosed deficiency. It is not intended for men with normal testosterone who want higher levels.

Eligible patients who cannot come to the clinic may be able to receive care by telehealth using self-administered injection therapy.

Pellet therapy and injections administered by clinical staff both require an in-person visit and are never provided remotely. Telehealth availability also depends on clinician licensure, state law, clinical appropriateness and controlled-substance requirements, and is confirmed during your evaluation.

Patients who can reasonably travel to our Laramie clinic may have access to three testosterone treatment pathways, when clinically appropriate: self-administered injections, injections administered by our clinical team at the clinic, and testosterone pellet therapy.

Your medical team determines which options are appropriate after evaluation.

Not if you are able to receive care locally in Laramie. Local patients may also have the option of clinic-administered injections or pellet therapy.

For patients receiving care entirely by telehealth, self-administered injections are the available testosterone delivery pathway in this program.

Yes. Local patients may choose to have testosterone injections administered by our clinical team at the clinic rather than giving injections themselves, when that treatment pathway is appropriate.

Tell us in the Get Started questionnaire. If you live near Laramie, the care team can discuss clinic-administered injections or pellet therapy with you.

If you are receiving care remotely, your response will be available to the medical team so they can discuss the appropriate next step.

No. Testosterone pellet insertion is an in-person procedure performed at the Laramie clinic. Pellet therapy is available only to patients who can travel to Laramie for the procedure and are appropriate candidates.

There is not a single mileage cutoff presented on the website. The important question is whether you can reasonably travel to the Laramie clinic for the in-person care your treatment pathway requires.

The Get Started questionnaire asks this near the beginning so we can show you the appropriate options.

If you do not live within reasonable driving distance of Laramie, the questionnaire routes you to the telehealth pathway.

Availability still depends on clinical appropriateness and whether telehealth treatment can legally be provided where you live.

You can still complete the Get Started questionnaire. Patients outside Wyoming are routed to the telehealth pathway rather than Laramie-based procedures.

Actual treatment availability depends on the medical team's ability to provide care in your state.

Potentially. Your preferred treatment pathway can be discussed with the medical team. Procedures such as pellet insertion and clinic-administered injections require in-person care in Laramie.

Your answers help us understand your location, symptoms, goals, treatment history, fertility concerns, treatment preferences and other information the care team may need.

If you continue through the standard testosterone evaluation pathway, the next step is the Men's Testosterone Panel.

The Men's Testosterone Panel is the laboratory testing step used as part of the testosterone evaluation process. It is purchased through the website for $149.

Laboratory results are reviewed together with your symptoms, history and clinical evaluation. Purchasing laboratory testing does not guarantee testosterone treatment or a prescription.

No. The questionnaire is designed to begin with simple routing questions rather than a lead form.

Your name, email and mobile number are collected later as part of checkout so you do not have to enter the same information twice.

Location determines which treatment pathways are practical. Patients who can come to Laramie may have access to self-administered injections, clinic-administered injections and pellet therapy.

Patients receiving care remotely are routed to the telehealth pathway.

Testosterone therapy can suppress sperm production, so fertility goals are important information for the medical team before treatment decisions are made.

Selecting a fertility concern does not by itself determine your treatment. It tells the provider that the issue should be discussed during your evaluation.

Yes. The Get Started questionnaire can also capture interest in services such as weight loss, peptides, sexual health, hair restoration, wellness, age management and skin care.

This information helps the care team understand your broader goals without making you complete another form.

No. The questionnaire helps organize your information and route you to the appropriate next step.

Testosterone therapy requires medical evaluation and appropriate laboratory findings, and a prescription is never guaranteed.

Low testosterone, or testosterone deficiency, is a clinical condition in which consistently low testosterone occurs together with symptoms and signs consistent with deficiency.

Both parts matter. Laboratory values alone, without symptoms, do not establish the condition, and symptoms alone, without confirmed low levels, do not either.

Diagnosis combines symptoms and signs with appropriately timed, repeated laboratory measurement of total testosterone, plus additional testing to identify the cause.

Morning testing is used because testosterone follows a daily rhythm, and repeat testing is used because a single value can be misleading.

The American Urological Association uses a total testosterone level of approximately 300 ng/dL as a reasonable cutoff supporting the diagnosis of low testosterone when symptoms and signs are present.

It is a diagnostic reference point, not an automatic treatment threshold. A number alone does not determine whether treatment is appropriate.

No. The questionnaire is a routing and intake tool, not a diagnosis. Laboratory evaluation happens as part of your clinical evaluation.

If you already have recent results, bring them to your visit — but they are not required to get started.

In men with confirmed low testosterone, randomized evidence shows improvement in sexual desire and sexual activity, with a smaller and more variable effect on erectile function.

Sexual symptoms often have contributors beyond hormones, including vascular health, medication, sleep and mood, so testosterone addresses only part of the picture.

Energy and fatigue are among the outcomes where guideline review describes the evidence as inconclusive.

The vitality trial within the Testosterone Trials did not show a significant benefit on its primary vitality measure. Some men report feeling different, but this is not presented as an expected outcome of treatment.

TRAVERSE, a randomized cardiovascular safety trial in more than 5,200 men with hypogonadism and cardiovascular disease or high risk, found major adverse cardiac events in 7.0% of the testosterone group and 7.3% of the placebo group, meeting its noninferiority criterion.

This does not prove testosterone has zero cardiovascular risk. The trial reported higher rates of atrial fibrillation, acute kidney injury and pulmonary embolism in the testosterone group, and FDA requires class-wide blood-pressure warnings on testosterone products.

Testosterone can raise hematocrit, and elevated hematocrit is one of the most common reasons therapy is dose-adjusted, paused or stopped.

A complete blood count is checked before starting and monitored during therapy.

Testosterone supplied from outside the body can suppress LH, FSH, intratesticular testosterone and sperm production, and in some men suppression is profound.

The Endocrine Society recommends against starting testosterone therapy in men planning fertility in the near term. Recovery after stopping varies between men in both degree and time. Tell us before you start, and the medical team will factor it into the plan.

Pellets are placed under the skin during a short in-office procedure and release testosterone over an extended interval rather than daily or weekly.

Pellet insertion requires an in-person visit to the Laramie clinic and is not a telehealth treatment. Because a pellet continues releasing testosterone after insertion and cannot be readily removed, the decision is made with your clinician after evaluation.